AptarGroup [ATR] vs Repligen [RGEN] Detailed Stock Comparison
AptarGroup
NYSE
Loading...
Repligen
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AptarGroup wins in 16 metrics, Repligen wins in 3 metrics, with 0 ties. AptarGroup appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AptarGroup | Repligen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.35 | 511.11 | AptarGroup |
| Price-to-Book Ratio | 3.43 | 3.21 | Repligen |
| Debt-to-Equity Ratio | 43.12 | 34.44 | Repligen |
| PEG Ratio | 23.74 | 63.78 | AptarGroup |
| EV/EBITDA | 12.88 | 53.25 | AptarGroup |
| Profit Margin (TTM) | 10.84% | -2.05% | AptarGroup |
| Operating Margin (TTM) | 15.17% | 6.36% | AptarGroup |
| EBITDA Margin (TTM) | 15.17% | 6.36% | AptarGroup |
| Return on Equity | 15.26% | -1.29% | AptarGroup |
| Return on Assets (TTM) | 7.10% | -0.90% | AptarGroup |
| Free Cash Flow (TTM) | $349.22M | $142.49M | AptarGroup |
| Dividend Yield | 0.90% | N/A | N/A |
| 1-Year Return | -2.22% | -32.53% | AptarGroup |
| Price-to-Sales Ratio (TTM) | 2.57 | 9.46 | AptarGroup |
| Enterprise Value | $10.29B | $6.36B | AptarGroup |
| EV/Revenue Ratio | 2.85 | 9.44 | AptarGroup |
| Gross Profit Margin (TTM) | 37.99% | 53.65% | Repligen |
| Revenue per Share (TTM) | $54 | $12 | AptarGroup |
| Earnings per Share (Diluted) | $5.78 | $-0.25 | AptarGroup |
| Beta (Stock Volatility) | 0.57 | 1.05 | AptarGroup |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AptarGroup vs Repligen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AptarGroup | 0.19% | -0.42% | -12.06% | -8.22% | -1.77% | -8.70% |
| Repligen | -1.84% | -6.29% | -13.32% | -12.84% | -27.58% | -22.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AptarGroup | -2.22% | 26.71% | 18.79% | 101.45% | 236.32% | 461.43% |
| Repligen | -32.53% | -55.67% | -22.56% | 220.39% | 3,286.93% | 3,276.67% |
Performance & Financial Health Analysis: AptarGroup vs Repligen
| Metric | ATR | RGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $9.27B | $6.38B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 585,720 | 1,113,780 |
| 90 Day Avg. Volume | 417,123 | 898,847 |
| Last Close | $140.75 | $111.43 |
| 52 Week Range | $130.85 - $178.03 | $102.97 - $182.52 |
| % from 52W High | -20.94% | -38.95% |
| All-Time High | $178.03 (Nov 11, 2024) | $327.32 (Sep 20, 2021) |
| % from All-Time High | -20.94% | -65.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.15% |
| Quarterly Earnings Growth | 0.24% | 1.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | -0.02% |
| Operating Margin (TTM) | 0.15% | 0.06% |
| Return on Equity (TTM) | 0.15% | -0.01% |
| Debt to Equity (MRQ) | 43.12 | 34.44 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.04 | $35.34 |
| Cash per Share (MRQ) | $2.58 | $12.41 |
| Operating Cash Flow (TTM) | $616.20M | $164.14M |
| Levered Free Cash Flow (TTM) | $291.79M | $116.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.90% | N/A |
| Last 12-Month Dividend | $1.35 | N/A |
Valuation & Enterprise Metrics Analysis: AptarGroup vs Repligen
| Metric | ATR | RGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.35 | 511.11 |
| Forward P/E | 23.74 | 63.78 |
| PEG Ratio | 23.74 | 63.78 |
| Price to Sales (TTM) | 2.57 | 9.46 |
| Price to Book (MRQ) | 3.43 | 3.21 |
| Market Capitalization | ||
| Market Capitalization | $9.27B | $6.38B |
| Enterprise Value | $10.29B | $6.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.85 | 9.44 |
| Enterprise to EBITDA | 12.88 | 53.25 |
| Risk & Other Metrics | ||
| Beta | 0.57 | 1.05 |
| Book Value per Share (MRQ) | $41.04 | $35.34 |
Financial Statements Comparison: AptarGroup vs Repligen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATR | RGEN |
|---|---|---|
| Revenue/Sales | $887.31M | $169.17M |
| Cost of Goods Sold | $550.89M | $78.42M |
| Gross Profit | $336.41M | $90.76M |
| Research & Development | N/A | $12.92M |
| Operating Income (EBIT) | $115.49M | $6.58M |
| EBITDA | $186.15M | $29.07M |
| Pre-Tax Income | $106.02M | $7.94M |
| Income Tax | $27.35M | $2.11M |
| Net Income (Profit) | $78.66M | $5.83M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATR | RGEN |
|---|---|---|
| Cash & Equivalents | $125.84M | $697.23M |
| Total Current Assets | $1.51B | $1.03B |
| Total Current Liabilities | $1.21B | $152.00M |
| Long-Term Debt | $612.02M | $668.54M |
| Total Shareholders Equity | $2.55B | $1.99B |
| Retained Earnings | $2.42B | $413.18M |
| Property, Plant & Equipment | $66.57M | $265.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATR | RGEN |
|---|---|---|
| Operating Cash Flow | $100.50M | $14.16M |
| Capital Expenditures | $79,000 | $-3.52M |
| Free Cash Flow | $23.41M | $10.58M |
| Debt Repayment | $-4.55M | N/A |
| Common Stock Repurchase | $-80.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ATR | RGEN |
|---|---|---|
| Shares Short | 901,388 | 3.40M |
| Short Ratio | 2.53 | 4.65 |
| Short % of Float | 0.02% | 0.08% |
| Average Daily Volume (10 Day) | 585,720 | 1,113,780 |
| Average Daily Volume (90 Day) | 417,123 | 898,847 |
| Shares Outstanding | 66.50M | 56.09M |
| Float Shares | 65.33M | 52.57M |
| % Held by Insiders | 0.01% | 0.06% |
| % Held by Institutions | 0.96% | 1.04% |
Dividend Analysis & Yield Comparison: AptarGroup vs Repligen
| Metric | ATR | RGEN |
|---|---|---|
| Last 12-Month Dividend | $1.35 | N/A |
| Last 12-Month Dividend Yield | 0.90% | N/A |
| 3-Year Avg Annual Dividend | $1.50 | N/A |
| 3-Year Avg Dividend Yield | 0.32% | N/A |
| 3-Year Total Dividends | $4.51 | N/A |
| Ex-Dividend Date | Feb 05, 2025 | N/A |